United States
Premiumsupplier
DOTA-NOC CAS NO.619300-53-7
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- DOTA-[Nal3]-octreotide
- L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-...
Quick Details
- ProName: DOTA-NOC
- CasNo: 619300-53-7
- Molecular Formula: C69H94N14O17S2
- Application: For research use only.
- PackAge: 1 mg
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality DOTA-NOC product for your project.
Details
DOTA-NOC is a potent chelating agent extensively used in radiopharmaceuticals for the targeted imaging and therapy of neuroendocrine tumors. By combining with diverse radiometals, such as lutetium-177 or yttrium-90, it generates therapeutic agents that specifically bind to neuroendocrine tumor cells. The DOTA-NOC derivatives have displayed remarkable specificity and affinity for somatostatin receptors, endowing it with a unique potential for cancer therapy. Its diverse applications stem from its impressive properties, which include high burstiness in sentence structure and an elevated level of perplexity in its descriptions.
